Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
PHASE2
This phase II trial studies fludarabine phosphate and total-body irradiatio...
Status
Completed
Location
Children's Hospital and Research Center at Oakland
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)
PHASE1
Background:
Adult T-cell leukemia (ATL) is a rare blood cancer. Researcher...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike